Rights to Improvements. (a) Chiva shall have a right to make Improvements to the Licensed Technology, and to utilize such Improvements to make, have made, use, sell, have sold and import Licensed Products in the Territory. Chiva hereby grants to Ligand a non-exclusive, perpetual right and license in the Territory, without the right to grant sublicenses, to make, have made, use, sell, have sold, import and export Improvements made by or on behalf of Chiva during the Term.
(b) Subject to the license granted to Ligand pursuant to Section 2.4(a), Improvements made by or on behalf of Chiva shall be owned and/or controlled exclusively by Chiva. For purposes of this Section 2.4(b), ownership of an Improvement shall be based on inventorship as determined in accordance with the patent law of the country in which the Improvement is reduced to practice.
Rights to Improvements. During the term of this Agreement, LICENSOR agrees to advise LICENSEE in writing on at least a semi-annual basis of any Improvements made by LICENSOR. Such LICENSOR Improvements shall become Licensed IP and be subject to the license right granted in Section 2.1; however, no additional royalty fees or other consideration shall be due for the use of such Improvements by LICENSEE. During the term of this Agreement, LICENSEE agrees to advise LICENSOR in writing on at least a semi-annual basis of any Improvements made by LICENSEE.
Rights to Improvements. If Receiving Party conceives of any invention or improvement as a result of the use of Disclosing Party’s Confidential Information, Receiving Party shall assign all rights, title and interest in that invention to Disclosing Party. An invention includes without limitation any programs, software, manufactures, methods, processes, uses, apparatuses, designs, configurations of any kind, works of authorship, or intellectual property, whether patentable or not.
Rights to Improvements. Apath agrees that use by Pharmasset of the licensed Tangible Property as provided herein within the Field of Use shall not give rise to any claim by Apath against Pharmasset with respect to Pharmasset’s intellectual property, including Pharmasset’s pharmaceutical product candidates and products, subject to the following: (i) so long as such pharmaceutical product candidates and products do not include any biological material containing, in whole or in part, Tangible Property or Tangible Property Improvements, as defined below; (ii) so long as such candidates and products do not include a [***] Inhibitor; and (iii)
Rights to Improvements. (a) Improvements shall be automatically included as part of the Acer Know-How and, to the extent Improvements result in applications for patents, whether patentable or not, shall be automatically included as part of the Acer Patents. Each Party agrees to use reasonable efforts to disclose to the other Party any and all Improvements and to promptly update Exhibit A attached hereto from time to time, as may be requested by either Party in writing, to reflect the inclusion of any Improvements in the Acer Patents.
(b) Subject to the rights granted to Relief in Section 9.2, Acer shall own all right, title and interest in and to all Improvements. Relief agrees and hereby irrevocably transfers and assigns to Acer any and all such rights, title and interest in and to all Improvements, and will perform and, if necessary, obligate its personnel to perform any and all other reasonable acts necessary to assist Acer in obtaining, maintaining, implementing, securing and perfecting any and all such rights, title and interest, including executing the necessary documents by Relief or its personnel.
Rights to Improvements. Licensee and its permitted Sublicensees shall have a right to make Improvements to the Licensed Technology, and to utilize such Improvements to develop, make, have made, use, sell, have sold, import and export Products in the Field in the Territory.
Rights to Improvements. During the term of this Agreement, LICENSOR agrees to advise LICENSEE in writing on at least a semi-annual basis of any Improvements made by LICENSOR. Such LICENSOR Improvements shall become Licensed IP and be subject to the license right granted in Section 2.1; however, no additional royalty fees or other consideration shall be due for the use of such ___________________ ***** VISTAGEN THERAPEUTICS, INC. HAS REQUESTED THAT THE OMITTED PORTIONS OF THIS DOCUMENT, WHICH ARE INDICATED BY [*****], BE AFFORDED CONFIDENTIAL TREATMENT. VISTAGEN THERAPEUTICS, INC. HAS SEPARATELY FILED THE OMITTED PORTIONS OF THE DOCUMENT WITH THE SECURITIES AND EXCHANGE COMMISSION. Improvements by LICENSEE. During the term of this Agreement, LICENSEE agrees to advise LICENSOR in writing on at least a semi-annual basis of any Improvements made by LICENSEE.
Rights to Improvements. Wireless Solutions agrees to notify Retix promptly in writing of the existence of and the specifications for any improvements, enhancements, modifications or amendments to the Licensed Materials (the "IMPROVEMENTS") that Wireless Solutions does not market as new products and of any versions to or new versions of the Licensed Materials that Wireless Solutions markets or new products which it has developed and proposes to make available to any third party (the "TECHNOLOGIES," and collectively with the Improvements, the "NEW TECHNOLOGIES"). Until the consummation of Wireless Solutions' Initial Public Offering (as defined in the Master Agreement), Wireless Solutions shall make any such New Technologies available for use by Retix on terms no less favorable than those provided by Wireless Solutions to its most favored customer and at a rate equal to the greater of Wireless Solutions' most favored customer discount or a 50% discount off the then-current Wireless Solutions suggested end-user price for such New Technology, in each case for Wireless Solutions customers contemporaneously purchasing the Licensed Materials under similar terms. Following the consummation of Wireless Solutions' Initial Public Offering, Wireless Solutions shall make any such New Technologies available for use by Retix on terms no less favorable than those provided by Wireless Solutions to Equivalent Purchasers (as defined below) of similar Wireless Solutions products and services. As used in the foregoing sentence, the term "EQUIVALENT PURCHASERS" shall mean purchasers of Wireless Solutions products or services who (i) are not affiliated with Wireless Solutions, and (ii) purchase such products or services on terms that are substantially equivalent to those applicable to Retix.
Rights to Improvements. For a period of five (5) years from the termination of the Research Program, Roche shall acquire an exclusive (non-exclusive in the countries of the world in which this Section might otherwise be deemed to violate restrictive trade practices laws), worldwide, royalty-free license to any Improvements made by Helicon, but only to the extent necessary to guarantee that Roche can fully enjoy all the rights granted to it pursuant to Article 5. Helicon shall promptly and fully notify Roche of any such Improvements made by Helicon, including costs. All such Improvements shall be included within the scope of this Agreement.
Rights to Improvements. LICENSEE will receive an option to LICENSOR Improvements at terms to be negotiated later in good faith between the Parties. LICENSOR will receive a license to all of the LICENSEE Improvements.
